Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials ; volume:25 ; number:1 ; day:11 ; month:3 ; year:2024 ; pages:1-10 ; date:12.2024
The journal of headache and pain ; 25, Heft 1 (11.3.2024), 1-10, 12.2024
- Urheber
-
Rizzoli, Paul
Marmura, Michael J.
Robblee, Jennifer
McVige, Jennifer
Sacco, Sara
Nahas, Stephanie J.
Ailani, Jessica
Abreu Ferreira, Rosa De
Ma, Julia
Smith, Jonathan H.
Dabruzzo, Brett
Ashina, Messoud
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-024-01736-z
- URN
-
urn:nbn:de:101:1-2405122104440.046550662476
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rizzoli, Paul
- Marmura, Michael J.
- Robblee, Jennifer
- McVige, Jennifer
- Sacco, Sara
- Nahas, Stephanie J.
- Ailani, Jessica
- Abreu Ferreira, Rosa De
- Ma, Julia
- Smith, Jonathan H.
- Dabruzzo, Brett
- Ashina, Messoud
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Unmet Needs in Preventive Treatment of Migraine
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Acute and preventive treatment of menstrual migraine: a meta-analysis
Brain imaging of preventive migraine medication : pharmacological modulation of nociceptive trigemanial processing
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Unmet Needs in Preventive Treatment of Migraine
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Acute and preventive treatment of menstrual migraine: a meta-analysis
Brain imaging of preventive migraine medication : pharmacological modulation of nociceptive trigemanial processing
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Unmet Needs in Preventive Treatment of Migraine
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Acute and preventive treatment of menstrual migraine: a meta-analysis
Brain imaging of preventive migraine medication : pharmacological modulation of nociceptive trigemanial processing
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials